ESR2 and breast carcinoma: We observed limited associations between breast cancer case characteristics and the investigated tumor markers, and no significant heterogeneity in associations between circulating 27HC and breast cancer risk by breast tumor CYP27A1, CYP7B1, or ERβ expression, and limited heterogeneity by LXR-β.